share_log

8-K: Current report

8-K: Current report

8-K:重大事件
美股SEC公告 ·  10/09 08:31

Moomoo AI 已提取核心訊息

On October 4, 2024, 180 Life Sciences Corp. announced it had regained compliance with Nasdaq's minimum shareholder equity requirement, following a decision by the Nasdaq Hearing Panel on July 1, 2024. The company will be monitored for one year to ensure ongoing compliance. However, 180 Life Sciences remains non-compliant with Nasdaq's audit committee requirements, specifically the need for at least three independent directors. The company has until the earlier of its next annual shareholders' meeting or May 7, 2025, to meet this requirement, with a deadline of November 4, 2024, if the shareholders' meeting occurs before that date. Failure to comply may lead to delisting, but the company is actively seeking qualified independent directors to regain compliance. Additionally, on October 9, 2024, 180 Life Sciences issued a press release about...Show More
On October 4, 2024, 180 Life Sciences Corp. announced it had regained compliance with Nasdaq's minimum shareholder equity requirement, following a decision by the Nasdaq Hearing Panel on July 1, 2024. The company will be monitored for one year to ensure ongoing compliance. However, 180 Life Sciences remains non-compliant with Nasdaq's audit committee requirements, specifically the need for at least three independent directors. The company has until the earlier of its next annual shareholders' meeting or May 7, 2025, to meet this requirement, with a deadline of November 4, 2024, if the shareholders' meeting occurs before that date. Failure to comply may lead to delisting, but the company is actively seeking qualified independent directors to regain compliance. Additionally, on October 9, 2024, 180 Life Sciences issued a press release about its re-compliance with the Equity Rule and its strategic shift towards the iGaming sector, following the acquisition of a leading iGaming platform technology. The company aims to leverage this technology to enter the rapidly growing global iGaming market, which is projected to reach over $160 billion by 2026. The new platform is expected to launch in the first quarter of 2025 and will incorporate blockchain technology for enhanced security and flexibility in payment options, including cryptocurrencies.
180 life sciences公司於2024年10月4日宣佈已恢復符合納斯達克的最低股東權益要求,這是根據納斯達克聽證會在2024年7月1日的決定。該公司將在一年內接受監督以確保持續符合要求。然而,180 life sciences公司仍不符合納斯達克的審計委員會要求,特別是至少需要三名獨立董事的要求。該公司必須在其下一次年度股東大會或2025年5月7日之前滿足此要求,若股東大會在此日期之前舉行,則最後期限爲2024年11月4日。不遵守可能導致除牌,但該公司正在積極尋找合格的獨立董事以恢復符合。此外,在2024年10月9日,180 life sciences發表新聞稿,宣佈重新符合股權規則...展開全部
180 life sciences公司於2024年10月4日宣佈已恢復符合納斯達克的最低股東權益要求,這是根據納斯達克聽證會在2024年7月1日的決定。該公司將在一年內接受監督以確保持續符合要求。然而,180 life sciences公司仍不符合納斯達克的審計委員會要求,特別是至少需要三名獨立董事的要求。該公司必須在其下一次年度股東大會或2025年5月7日之前滿足此要求,若股東大會在此日期之前舉行,則最後期限爲2024年11月4日。不遵守可能導致除牌,但該公司正在積極尋找合格的獨立董事以恢復符合。此外,在2024年10月9日,180 life sciences發表新聞稿,宣佈重新符合股權規則及其戰略轉向iGaming板塊,此舉是在收購領先iGaming平台技術後進行的。該公司旨在利用這項技術進入預計到2026年將達到超過1600億美元的全球iGaming市場增長迅速的市場。新平台預計將於2025年第一季度推出,並將整合區塊鏈技術以提升安全性和靈活性,提供包括加密貨幣在內的支付選項。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息